Default Category
-
Cipla (Spanish version)
Deshpande, Rohit; Winig, LauraCase HBS-520S15MarketingThe head of Cipla, a $325-million-dollar Indian pharmaceutical company and seller of low-cost AIDS drugs to South Africa, must decide what to do about Cipla's future. With India poised to enforce international patents in only two years, much of Cipla's product line could become unsaleable (given that it is based on product patents protected in industrialized countries). Describes Cipla's role in forcing global pharmaceutical companies to lower th...Starting at €8.20
-
Evolko Systems: COVID-19 Pandemic and Business Model Pivot - Teaching Note
Vania Sakelaris; Bhagwati Prasad; Michele McGowan; Aishwarya Athanikar; Sheetal Sippy; Bhairavi TamhankarTeaching Note IVEY-W25232-EMarketing, Service and Operations ManagementTeaching note for product W25231.Starting at €0.00
-
Cipla 2011 (Spanish version)
Deshpande, Rohit; Sucher, Sandra J.; Winig, LauraCase HBS-517S04Business Ethics and Corporate Social ResponsibilityDr. Yusuf Hamied, head of the Indian pharma and generics manufacturing company Cipla, is weighing options for how to continue to support the global fight against HIV/AIDS while positioning his company for growth in a changing regulatory landscape.Starting at €8.20
-
Evolko Systems: COVID-19 Pandemic and Business Model Pivot
Vania Sakelaris; Bhagwati Prasad; Michele McGowan; Aishwarya Athanikar; Sheetal Sippy; Bhairavi TamhankarCase IVEY-W25231-EMarketing, Service and Operations ManagementIn March 2020, Evolko Systems Private Limited encountered several strategic and operational effects resulting from the outbreak of the COVID-19 pandemic. The private health care technology company, which was based in California, United States, used artificial intelligence and machine learning to provide products and services to India’s health care market. The company’s chief executive officer had to mitigate risk from the pandemic using his compa...Starting at €8.20